Clinical Trial Update: The Combination of Upadacitinib and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of upadacitinib and high-dose dexamethasone as first-line treatment for adults with immune thrombocytopenia; n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Upadacitinib (upadacitinib)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Immune Thrombocytopenia | Phase 2 | Status: NOT_YET_RECRUITING